BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 3884426)

  • 41. A comparison of 4-week peptic ulcer healing rates following treatment with antacids and ranitidine.
    Bezuidenhout DJ; Perold JG; Adams G
    S Afr Med J; 1984 Jun; 65(25):1007-9. PubMed ID: 6328685
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A single evening dose of 300 mg ranitidine in the treatment of acute attacks of gastric and duodenal ulcers. Evaluation of 1,208 patients].
    Bories P; Tournade JM; Alberola B; Pappo M
    Ann Gastroenterol Hepatol (Paris); 1988 Oct; 24(5):227-32. PubMed ID: 3061358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer.
    Thomas JM; Misiewicz G
    Clin Gastroenterol; 1984 May; 13(2):501-41. PubMed ID: 6146417
    [No Abstract]   [Full Text] [Related]  

  • 44. Morning versus evening dose: a comparison of three H2-receptor blockers in duodenal ulcer healing.
    Khasawneh SM; Affarah HB
    Am J Gastroenterol; 1992 Sep; 87(9):1180-2. PubMed ID: 1519576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of ranitidine and cimetidine on gastric ulcer healing and recurrence.
    Dawson J; Jain S; Cockel R
    Scand J Gastroenterol; 1984 Jul; 19(5):665-8. PubMed ID: 6089305
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ranitidine and cimetidine in prevention of duodenal ulcer relapse. A double-blind, randomised, multicentre, comparative trial.
    Gough KR; Korman MG; Bardhan KD; Lee FI; Crowe JP; Reed PI; Smith RN
    Lancet; 1984 Sep; 2(8404):659-62. PubMed ID: 6147693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.
    Gledhill T; Howard OM; Buck M; Paul A; Hunt RH
    Gut; 1983 Oct; 24(10):904-8. PubMed ID: 6311692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cimetidine, ranitidine and mifentidine in specific gastric and duodenal ulcer models.
    Del Soldato P; Ghiorzi A; Cereda E; Donetti A
    Pharmacology; 1985; 30(1):45-51. PubMed ID: 2858110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of ranitidine and cimetidine in duodenal ulcer healing.
    Barr GD; Paris CH; Middleton WR; Piper DW
    Med J Aust; 1982 Jul; 2(2):83-5. PubMed ID: 6289058
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparative trial of ranitidine 300 mg at night with ranitidine 150 mg twice daily in the treatment of duodenal and gastric ulcer.
    Farley A; Lévesque D; Paré P; Thomson AB; Sherbaniuk R; Archambault A; Mahoney K
    Am J Gastroenterol; 1985 Sep; 80(9):665-8. PubMed ID: 3898818
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of duodenal ulcer occurrence. Double-blind comparison of ranitidine and cimetidine.
    Bolin TD; Davis AE; Billington B
    J Clin Gastroenterol; 1987 Jun; 9(3):310-3. PubMed ID: 3302004
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of ranitidine on the content of glyceroglucolipids in gastric secretion of patients with gastric and duodenal ulcer.
    Sarosiek J; Slomiany BL; Slomiany A; Gabryelewicz A
    Scand J Gastroenterol; 1984 Jul; 19(5):650-4. PubMed ID: 6089304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative study of cimetidine and trimipramine in the short-term treatment of duodenal and gastric ulcer.
    Valnes K; Wetterhus S; Myren J; Arva P; Larsen S
    Scand J Gastroenterol; 1983 Jan; 18(1):33-8. PubMed ID: 6372066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of ranitidine and cimetidine ulcer maintenance therapy.
    Kurata JH; Koch GG; Nogawa AN
    J Clin Gastroenterol; 1987 Dec; 9(6):644-50. PubMed ID: 3327884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Maintenance therapy of duodenal and gastric ulcer with H2-receptor antagonists.
    Boyd EJ; Penston JG; Wormsley KG
    Scand J Gastroenterol Suppl; 1990; 178():72-8. PubMed ID: 2277972
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Comparative study of the efficacy of ranitidine, cimetidine (Asiloc), De-Nol and spirulina in the treatment of gastric and duodenal ulcer].
    Fica V; Andronescu D; Olteanu D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1987; 39(1):21-35. PubMed ID: 2884709
    [No Abstract]   [Full Text] [Related]  

  • 57. [Therapy with H2 receptor antagonists in childhood. Use of ranitidine in duodenal and gastric ulcer and reflux esophagitis].
    Bender SW
    Fortschr Med; 1992 Nov; 110(33):629-32. PubMed ID: 1478605
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ranitidine in the maintenance therapy of gastro-duodenal ulcer disease: Polish open multicentre study.
    Gibiński K; Nowak A; Gabryelewicz A; Szałaj W; Hasik J; Klincewicz H; Butruk E; Kosecki P; Pokora J; Radwan P
    Hepatogastroenterology; 1984 Aug; 31(4):180-2. PubMed ID: 6090287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative efficacy of cimetidine & ranitidine.
    Talwalkar PG
    J Assoc Physicians India; 1987 Sep; 35(9):670. PubMed ID: 3436946
    [No Abstract]   [Full Text] [Related]  

  • 60. Ranitidine in the treatment of gastric, prepyloric and duodenal ulcer--a controlled prospective double-blind trial.
    Darle N; Almskog B; Falk A; Fredriksen B; Gamklou R; Ivarsson L; Karlström L
    Ann Clin Res; 1984; 16(1):6-9. PubMed ID: 6331270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.